Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions express strong support for the study's promising results, often describing MDMA-assisted therapy as a 'game changer' or 'significant breakthrough,' with users engaging deeply by referencing specifics like the trial's design and potential FDA approval, highlighting both high interest and perceived impact.
Most discussions highlight the positive results and support the potential of MDMA-assisted therapy, indicating strong agreement with the study's findings.
Posts show high interest, often emphasizing the significance of the research and its implications for PTSD treatment.
Many comments include references to the methodology, success stories, and anticipated future approval, reflecting active and thoughtful engagement.
Overall conversations suggest this research is seen as a pivotal breakthrough, likely to influence future therapy options and regulatory decisions.
A successful efficacy trial from @MAPS utilizing MDMA for PTSD has just been published in Nature: “MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial” https://t.co/hBCrkK8GK5
Great news! #MDMA significantly attenuated PTSD symptomology versus placebo with therapy in published data in Nature Medicine, see “MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial” https://t.co/SD3yW1IVD3
#MDMA-assisted therapy for moderate to severe #PTSD: a randomized, placebo-controlled phase 3 trial sponsored by @MAPS Confirms prior findings of efficacy, moving towards submission for FDA approval . In @Nature https://t.co/yO8dWUYOGZ
【原著論文 (2/2)】 Mitchell, JM, et al. "MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial" Nat Med 29, 2473–2480 Pub 14 Sep 2023 https://t.co/T16V7Ce7Lt
Discover the evolving scientific research on psychedelics and their potential to treat depression, anxiety, PTSD, and addiction. Experts discuss the latest findings, regulatory challenges, and European initiatives…
Today's episode explores the structure and function of neurons, including communication, neurotransmitter production, and types of neurons. We highlight key contributions from neurobiologists and provide foundational…
This phase 3 clinical trial tested MDMA-assisted therapy for moderate to severe PTSD, showing significant symptom reduction. Participants experienced greater decreases in PTSD severity and functional impairment, with…
RT @parliamdidroghe: Curarsi cogli spichedelici? https://t.co/C7r8FsUYia
RT @parliamdidroghe: Curarsi cogli spichedelici? https://t.co/C7r8FsUYia
RT @parliamdidroghe: Curarsi cogli spichedelici? https://t.co/C7r8FsUYia
RT @parliamdidroghe: Curarsi cogli spichedelici? https://t.co/C7r8FsUYia
Curarsi cogli spichedelici? https://t.co/C7r8FsUYia
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://t.co/Tkb84iOVXL
Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial #science #publication #research #journal https://t.co/EBayIrAp48
性的虐待や暴行など、圧倒的な恐怖の体験によって引き起こされる心の病「PTSD（心的外傷後ストレス障害）」。その症状改善に合成麻薬のMDMAが効果があると、米カリフォルニア大などの研究チームが発表した。（https://t.co/jXO5z0Nifq） https://t.co/UIWe1QxdSr https://t.co/Lg8VKhjiSs
[2] Mitchell, J.M., Ot’alora G., M., van der Kolk, B. et al. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nat Med 29, 2473–2480 (2023). https://t.co/fvIfDXCV7E
RT @takatoh_life: 【原著論文 (2/2)】 Mitchell, JM, et al. "MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled ph…
【原著論文 (2/2)】 Mitchell, JM, et al. "MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial" Nat Med 29, 2473–2480 Pub 14 Sep 2023 https://t.co/T16V7Ce7Lt
@NotSoProf0und https://t.co/yClMZvcLTV https://t.co/AGArz6Jtm3
Обмеженість кількості досліджень. Якщо ми звернемось до UpToDate то вони пропонують 2 свіжих рандомізованих дослідження. Але є нюанс. Конфлікт інтересів в кожному з них це цілий список. https://t.co/lDUL0qDUhq https://t.co/FeeYM4PcUD https://t.co/JYLwmnyzyu
@richmondie e.g. MDMA therapy rapidly expanding as it is very effective with severe PTSD https://t.co/btdxzfr1Od
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/pfouCmIqnA via @Nature @MAPS @NatureMedicine #MDMA #Psychedelics The study from Nature Medicine involved a diverse group of participants with moderate to severe PTSD. https://t.co/OkMDE2s0DN
The 2/9/2024 #JournalClub presented "MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial." The recording is available free to all AAPP members. https://t.co/9ziXh7cU2H https://t.co/xhLKYkpFrJ
#Research reading: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/2teqDgwtIq
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/h4uBQKk7aM Therapy vs MDMA + therapy - improvements in both groups, but more so with MDMA
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/mOAXxvWTxl
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/rUvk2rMWuD
@NOBrainer_drugs MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/dLeHN2Zvmm https://t.co/kcJzmo9odw
The second, (September 2023), "Nature Medicine" paper the above "Nature" article is based upon, & links to: “MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial” 3/3 https://t.co/MKzEcAX2C5
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial #science #publication #research #journal https://t.co/UahMUKb0Hq
RT @jeffrey_ventre: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine h…
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://t.co/v1aUI6dKW1
RT @daniel_kraft: #MDMA-assisted therapy for moderate to severe #PTSD: a randomized, placebo-controlled phase 3 trial sponsored by @MAPS…
RT @daniel_kraft: #MDMA-assisted therapy for moderate to severe #PTSD: a randomized, placebo-controlled phase 3 trial sponsored by @MAPS…
RT @daniel_kraft: #MDMA-assisted therapy for moderate to severe #PTSD: a randomized, placebo-controlled phase 3 trial sponsored by @MAPS…
RT @daniel_kraft: #MDMA-assisted therapy for moderate to severe #PTSD: a randomized, placebo-controlled phase 3 trial sponsored by @MAPS…
#MDMA-assisted therapy for moderate to severe #PTSD: a randomized, placebo-controlled phase 3 trial sponsored by @MAPS Confirms prior findings of efficacy, moving towards submission for FDA approval . In @Nature https://t.co/yO8dWUYOGZ
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial #science #publication #research #publications https://t.co/skucqbijoc
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/Ew6BMUeT1k
RT @theradelics: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/1HN9rgtHfV…
述べました。承認されれば、米国はオーストラリアに次いで２番目の治療用MDMA承認国となります。Nature Medicine誌https://t.co/Saz1ibqrks
RT @GlobalPHObserv: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine htt…
RT @GlobalPHObserv: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine htt…
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://t.co/N0Bqv7ReNb
rdcu.be/dmlBU MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/1HN9rgtHfV https://t.co/xRfC4MFzef
@arprisonchap MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/uO6eKdtagK
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/ZJdFUkTAaj
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://t.co/khDnfw1CL9
"MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial" published in @NatureMedicine was one of our top rated articles on @altmetric this past week. You can read the #OpenAccess article here: https://t.co/NEpDHXafvF https://t.co/8bZiUCnLkR
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://t.co/oGX0AUb3Pw
This Phase IIIb trial (n=104) evaluated the efficacy and safety of MDMA-assisted therapy for individuals with moderate to severe PTSD. https://t.co/ck5BM5LS8f
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial https://t.co/YMOIpuPUVk #science #health #therapy #ptsd #phase #trial
RT @DrShaneMorris: Great news! #MDMA significantly attenuated PTSD symptomology versus placebo with therapy in published data in Nature Med…
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://t.co/CqKhst9Bes
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial (Jennifer M. Mitchell/Nature) Main Link | memeorandum Permalink
RT @DrShaneMorris: Great news! #MDMA significantly attenuated PTSD symptomology versus placebo with therapy in published data in Nature Med…
RT @DrShaneMorris: Great news! #MDMA significantly attenuated PTSD symptomology versus placebo with therapy in published data in Nature Med…
RT @Psilocybrain: A successful efficacy trial from @MAPS utilizing MDMA for PTSD has just been published in Nature: “MDMA-assisted th…
RT @DrShaneMorris: Great news! #MDMA significantly attenuated PTSD symptomology versus placebo with therapy in published data in Nature Med…
RT @Psilocybrain: A successful efficacy trial from @MAPS utilizing MDMA for PTSD has just been published in Nature: “MDMA-assisted th…
RT @psychedelethics: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine ht…
History in the making. @MAPS MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://t.co/3kaZgizhgs
RT @Psilocybrain: A successful efficacy trial from @MAPS utilizing MDMA for PTSD has just been published in Nature: “MDMA-assisted th…
New in @NatureMedicine: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
RT @Psilocybrain: A successful efficacy trial from @MAPS utilizing MDMA for PTSD has just been published in Nature: “MDMA-assisted th…
RT @wendyburn: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://…
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://t.co/a1x0J2IhHM
RT @Psilocybrain: A successful efficacy trial from @MAPS utilizing MDMA for PTSD has just been published in Nature: “MDMA-assisted th…
RT @Psilocybrain: A successful efficacy trial from @MAPS utilizing MDMA for PTSD has just been published in Nature: “MDMA-assisted th…
#MDMA -assisted therapy for moderate to severe #PTSD : a randomized, placebo-controlled phase 3 trial | Nature Medicine https://t.co/q4kIh3prlx
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine https://t.co/dRgBrzlIb6
A successful efficacy trial from @MAPS utilizing MDMA for PTSD has just been published in Nature: “MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial” https://t.co/hBCrkK8GK5
Great news! #MDMA significantly attenuated PTSD symptomology versus placebo with therapy in published data in Nature Medicine, see “MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial” https://t.co/SD3yW1IVD3
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial | Nature Medicine #MDMA #MAPS https://t.co/ennKDbycvG
EB